Earnings History Data for Orchard Therapeutics plc (ORTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Orchard Therapeutics plc

Orchard Therapeutics plc is a biopharmaceutical company. It offers medical research, gene therapy and inherited disorder treatment services which transforms the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. Orchard Therapeutics plc is based in London, United Kingdom.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
03-08-2023	PM		ORTX	Orchard Therapeutics plc	91.76	-0.07	-1.67	4.00	Orchard Therapeutics GAAP EPS of -$0.07 beats by $0.55, revenue of $7.3M beats by $0.81M [8/3/2023 8:44 AM]	5.29	0.21 (4.13%)	5.25	0.17 (3.35%)	3.60 - 7.20	69,848	20,000	3,139
Orchard Therapeutics Q2 2023 Earnings Preview [8/2/2023 4:08 PM] Orchard Therapeutics GAAP EPS of -$0.07 beats by $0.55, revenue of $7.3M beats by $0.81M [8/3/2023 8:44 AM]
15-05-2023	PM		ORTX	Orchard Therapeutics	101.00	-0.12	-1.78	0.00	Orchard Therapeutics GAAP EPS of -$0.12, revenue of $1.23M [5/15/2023 10:03 AM]	5.41	0.27 (5.25%)	5.22	0.08 (1.56%)	3.60 - 7.20	174,241	70,000	8,915
Orchard Therapeutics GAAP EPS of -$0.12, revenue of $1.23M [5/15/2023 10:03 AM]
06-03-2023	PM		ORTX	Orchard Therapeutics	61.00	-0.06	-0.18	0.00	Orchard Therapeutics GAAP EPS of -$0.06 beats by $0.15, revenue of $6.97M beats by $1.66M [3/6/2023 6:28 AM]	0.55	0.07 (14.58%)	0.52	0.04 (8.33%)	0.36 - 0.89	1,507,433	530,000	331,684
Orchard Therapeutics GAAP EPS of -$0.06 beats by $0.15, revenue of $6.97M beats by $1.66M [3/6/2023 6:28 AM] Orchard Therapeutics announces up to $188M strategic financing [3/6/2023 6:16 AM]
14-11-2022	PM	7:00 AM ET (Nov 14)	ORTX	Orchard Therapeutics plc	55.60	-0.37	-0.23	-0.29	Orchard Therapeutics GAAP EPS of -$0.37 misses by $0.13, revenue of $5.78M beats by $1.37M [11/14/2022 7:04 AM]	0.4595	-0.01 (-2.21%)	0.46	-0.01 (-2.11%)	0.41 - 1.80	238,350	190,000	235
Orchard Therapeutics GAAP EPS of -$0.37 misses by $0.13, revenue of $5.78M beats by $1.37M [11/14/2022 7:04 AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	ORTX	Orchard Therapeutics plc	75.51	-0.40	-0.25	-0.29	Orchard Therapeutics GAAP EPS of -$0.40 misses by $0.14, revenue of $4.37M beats by $1.19M [8/4/2022 8:57 AM]	0.5280	-0.02 (-3.10%)	3.92	-0.40 (-9.26%)	0.41 - 3.18	566,420	870,000	51,552
Orchard Therapeutics GAAP EPS of -$0.40 misses by $0.14, revenue of $4.37M beats by $1.19M [8/4/2022 8:57 AM]
12-05-2022	PM	7:00 AM ET (May 12)	ORTX	Orchard Therapeutics plc	56.54	-0.35	-0.25	-0.31	Orchard Therapeutics GAAP EPS of -$0.35 misses by $0.10, revenue of $5.52M beats by $1.48M [5/12/2022 7:03 AM]	0.4225	-0.02 (-3.54%)	0.43	-0.01 (-2.95%)	0.41 - 5.99	1,013,873	670,000	26,823
Orchard Therapeutics Q1 2022 Earnings Preview [5/11/2022 12:34 PM] Orchard Therapeutics GAAP EPS of -$0.35 misses by $0.10, revenue of $5.52M beats by $1.48M [5/12/2022 7:03 AM] Orchard Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Commercial Progress [May-12-22 07:00AM]
30-03-2022	PM	7:45 AM ET (Mar 30)	ORTX	Orchard Therapeutics plc	94.12	-0.29	-0.28	-0.34	Orchard to cut ~30% workforce amid plans to refine portfolio; reports Q4 results [3/30/2022 9:57 AM]	0.7370	-0.04 (-5.51%)	0.75	-0.03 (-3.78%)	0.68 - 7.47	625,793	590,000	36,963
Orchard to cut ~30% workforce amid plans to refine portfolio; reports Q4 results [3/30/2022 9:57 AM] Orchard Therapeutics Extends Runway into 2024, Focusing HSC Gene Therapy Platform Exclusively on Severe Neurometabolic Diseases and Research Platform [Mar-30-22 07:00AM] Orchard Therapeutics Plans To Seek Strategic Options For Immunodeficiency Programs, Cuts Workforce [Mar-30-22 12:02PM]
04-11-2021	PM	7:00 AM ET (Nov 4)	ORTX	Orchard Therapeutics	252.00	-0.29	-0.27	0.00	Orchard Therapeutics EPS misses by $0.04, misses on revenue [11/4/2021 9:19 AM]	1.85	-0.21 (-10.19%)	2.07	0.01 (0.49%)	1.84 - 9.08	1,263,273	680,000	3,058
Orchard Therapeutics EPS misses by $0.04, misses on revenue [11/4/2021 9:19 AM] Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates [Nov-04-21 07:45AM]
04-08-2021	PM	7:00 AM ET (Aug 4)	ORTX	Orchard Therapeutics Plc Sponsored Adr	353.00	-0.29	-0.32	0.00	Orchard Therapeutics EPS beats by $0.04 [8/4/2021 7:29 AM]	2.90	0.11 (3.94%)	2.90	0.0 (0.00%)	2.79 - 9.08	1,004,239	720,000	10,600
Orchard Therapeutics EPS beats by $0.04 [8/4/2021 7:29 AM] Orchard Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Updates [Aug-04-21 07:00AM]
13-05-2021	PM		ORTX	Orchard Therapeutics plc	636.52	-0.31	-0.33	-0.51	Orchard Therapeutics EPS beats by $0.03 [5/13/2021 7:35 AM]	5.00	-0.50 (-9.09%)	5.55	0.05 (0.91%)	3.76 - 10.78	514,197	390,000	458
Orchard Therapeutics EPS beats by $0.03 [5/13/2021 7:35 AM] Orchard Therapeutics Reports First Quarter 2021 Financial Results and Provides Recent Business Updates [May-13-21 07:00AM]
03-11-2020	PM	7:00 AM ET (Nov 3)	ORTX	Orchard Therapeutics plc	388.36	-0.20	-0.44	-0.38	Orchard Therapeutics EPS beats by $0.26, beats on revenue [11/3/2020 7:09 AM]	4.60	-0.04 (-0.86%)	4.60	0.0 (0.00%)	3.76 - 15.93	413,281	534,463	101

06-08-2020	PM	7:00 AM ET (Aug 6)	ORTX	Orchard Therapeutics plc	492.15	-0.48	-0.43	-0.56	Orchard Therapeutics EPS misses by $0.05, beats on revenue [8/6/2020 7:11 AM]	4.54	-0.35 (-7.16%)	4.90	0.01 (0.20%)	4.46 - 17.48	577,286	386,975	298